These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1576669)

  • 41. Laboratory assays for the evaluation of recombinant hirudin.
    Walenga JM; Hoppensteadt D; Koza M; Wallock M; Pifarre R; Fareed J
    Haemostasis; 1991; 21 Suppl 1():49-63. PubMed ID: 1894197
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increasing effect of vanadate on lipoprotein lipase activity in isolated rat fat pads.
    Sera M; Tanaka K; Morita T; Ueki H
    Arch Biochem Biophys; 1990 Jun; 279(2):291-7. PubMed ID: 2161642
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vanadate inhibition of fungal PhyA and bacterial AppA2 histidine acid phosphatases.
    Ullah AH; Sethumadhavan K; Mullaney EJ
    J Agric Food Chem; 2011 Mar; 59(5):1739-43. PubMed ID: 21294512
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vanadate inhibits the ATPase activity and DNA binding capability of bacterial MutS. A structural model for the vanadate-MutS interaction at the Walker A motif.
    Pezza RJ; Villarreal MA; Montich GG; Argaraña CE
    Nucleic Acids Res; 2002 Nov; 30(21):4700-8. PubMed ID: 12409461
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The mechanism of action of rivaroxaban--an oral, direct Factor Xa inhibitor--compared with other anticoagulants.
    Samama MM
    Thromb Res; 2011 Jun; 127(6):497-504. PubMed ID: 20888031
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vanadate augments insulin-stimulated insulin receptor kinase activity and prolongs insulin action in rat adipocytes. Evidence for transduction of amplitude of signaling into duration of response.
    Fantus IG; Ahmad F; Deragon G
    Diabetes; 1994 Mar; 43(3):375-83. PubMed ID: 7508873
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-Xa activity of human hepatic triglyceride lipase.
    Gray E; Bengtsson-Olivecrona G; Olivecrona T; Barrowcliffe TW
    J Lab Clin Med; 1987 Jun; 109(6):653-9. PubMed ID: 3585139
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma.
    Ofosu FA; Lormeau JC; Craven S; Dewar L; Anvari N
    Thromb Haemost; 1994 Dec; 72(6):862-8. PubMed ID: 7740455
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of Chitosan Derivative N-[(2-Hydroxy-3-Trimethylammonium)Propyl]Chloride on Anticoagulant Activity of Guinea Pig Plasma.
    Drozd NN; Shagdarova BT; Il'ina AV; Varlamov VP
    Bull Exp Biol Med; 2017 Jul; 163(3):340-343. PubMed ID: 28744652
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Amblyomin-X having a Kunitz-type homologous domain, is a noncompetitive inhibitor of FXa and induces anticoagulation in vitro and in vivo.
    Branco VG; Iqbal A; Alvarez-Flores MP; Sciani JM; de Andrade SA; Iwai LK; Serrano SM; Chudzinski-Tavassi AM
    Biochim Biophys Acta; 2016 Oct; 1864(10):1428-35. PubMed ID: 27479486
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anticoagulant activity of captopril.
    Brecher AS; Murrey SJ; Gray KD; Poulimenos JN
    J Cardiovasc Pharmacol; 2008 Jan; 51(1):99-105. PubMed ID: 18209575
    [TBL] [Abstract][Full Text] [Related]  

  • 52. From selective substrate analogue factor Xa inhibitors to dual inhibitors of thrombin and factor Xa. Part 3.
    Dönnecke D; Schweinitz A; Stürzebecher A; Steinmetzer P; Schuster M; Stürzebecher U; Nicklisch S; Stürzebecher J; Steinmetzer T
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3322-9. PubMed ID: 17462889
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of different anticoagulants on thrombin generation.
    Petros S; Siegemund T; Siegemund A; Engelmann L
    Blood Coagul Fibrinolysis; 2006 Mar; 17(2):131-7. PubMed ID: 16479195
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel trypsin Kazal-type inhibitor from Aedes aegypti with thrombin coagulant inhibitory activity.
    Watanabe RM; Soares TS; Morais-Zani K; Tanaka-Azevedo AM; Maciel C; Capurro ML; Torquato RJ; Tanaka AS
    Biochimie; 2010 Aug; 92(8):933-9. PubMed ID: 20363282
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Measurement of the kinetics of inhibition of activated coagulation factor X in human plasma: the effect of plasma and inhibitor concentration.
    Jesty J
    Anal Biochem; 1986 Feb; 152(2):402-11. PubMed ID: 2421604
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of the oral, direct factor xa inhibitor rivaroxaban on platelet-induced thrombin generation and prothrombinase activity.
    Graff J; von Hentig N; Misselwitz F; Kubitza D; Becka M; Breddin HK; Harder S
    J Clin Pharmacol; 2007 Nov; 47(11):1398-407. PubMed ID: 17873238
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship between ex vivo anti-proteinase (factor Xa and thrombin) assays and in vivo anticoagulant effect of very low molecular weight heparin, CY222.
    Tew CJ; Lane DA; Thompson E; Ireland H; Curtis JR
    Br J Haematol; 1988 Nov; 70(3):335-40. PubMed ID: 2849981
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Simultaneous determination of zymogen activation time and zymogen level using chromogenic substrates in blood coagulation analysis].
    Svendsen L; Brogli M; Stocker K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):150-6. PubMed ID: 6177596
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anticoagulant effect of inositol hexasulfate as measurable by clotting times of fibrinogen and recalcified plasma.
    Oshima G
    Thromb Res; 1990 May; 58(3):243-50. PubMed ID: 2353338
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vanadate affects nuclear division and induces aberrantly-shaped cells during subsequent cytokinesis in Tetrahymena.
    Nilsson JR
    J Eukaryot Microbiol; 1999; 46(1):24-33. PubMed ID: 10188258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.